L'Oréal USA settles the first hair relaxer cancer trial in Chicago
Four women who sued L'Oréal's US subsidiary and other relaxer makers in Cook County, Illinois, settled on November 16, a week after their trial began in Chicago. The amount is confidential and no jury reached a verdict. L'Oréal says it remains confident in the safety of its SoftSheen-Carson relaxers. The deal covers only those four state cases. More than 12,700 cases are still pending in the federal case in Chicago, where the first trial is set for September 7, 2027. Minnesota and Arizona have also sued L'Oréal over how relaxers were marketed. The claims are unproven, and L'Oréal says they lack merit.
Why it matters
These products were marketed heavily to Black women for decades. A settlement isn't a finding that relaxers cause cancer, and there is no fund or claim form for anyone else. This is news coverage, not legal or medical advice.
The story so far
Arizona's attorney general sues L'Oréal over relaxer marketing.
The federal case reaches 12,381 cases.
Judge Mary Rowland lets the plaintiffs' epidemiologist testify on cancer risk and limits part of a toxicologist's testimony.
Minnesota's attorney general sues L'Oréal.
The federal case reaches 12,743 cases.
The first hair relaxer cancer trial opens in Cook County, Illinois, with four plaintiffs.
The four plaintiffs settle with L'Oréal USA and other makers for a confidential amount.
First federal trial
